See Permitted Daily Exposure.
Glossary
PDE
03.25.13
-
Promotions & Moves
Akebia Therapeutics Names CMO
Jain to lead clinical development of the company’s HIF pipeline
-
Breaking News | Fill/Finish | Industry News | Packaging & Tracking | Vials
HCPC Study Reveals Degradation Risk
Evaluates conventional packaging vs high barrier unit dose blisters
-
-
Cleaning Validation | Validation
The Good and the Bad of ISPE’s Risk-MaPP
An expert finds flaws in the new Risk-MaPP Guide
